KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

LifeMD (LFMD) Profit After Tax (2016 - 2025)

LifeMD filings provide 14 years of Profit After Tax readings, the most recent being $20.0 million for Q4 2025.

  • On a quarterly basis, Profit After Tax rose 397.74% to $20.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $17.0 million, a 173.94% increase, with the full-year FY2025 number at $14.4 million, up 161.94% from a year prior.
  • Profit After Tax hit $20.0 million in Q4 2025 for LifeMD, up from -$3.8 million in the prior quarter.
  • In the past five years, Profit After Tax ranged from a high of $20.0 million in Q4 2025 to a low of -$18.0 million in Q4 2021.
  • Median Profit After Tax over the past 5 years was -$6.3 million (2023), compared with a mean of -$6.6 million.
  • Biggest five-year swings in Profit After Tax: crashed 393.98% in 2021 and later surged 397.74% in 2025.
  • LifeMD's Profit After Tax stood at -$18.0 million in 2021, then skyrocketed by 33.72% to -$11.9 million in 2022, then soared by 68.73% to -$3.7 million in 2023, then tumbled by 79.66% to -$6.7 million in 2024, then surged by 397.74% to $20.0 million in 2025.
  • The last three reported values for Profit After Tax were $20.0 million (Q4 2025), -$3.8 million (Q3 2025), and -$1.1 million (Q2 2025) per Business Quant data.